Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Jan;95(1):158–166. doi: 10.1172/JCI117633

Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.

G F Lewis 1, K D Uffelman 1, L W Szeto 1, B Weller 1, G Steiner 1
PMCID: PMC295395  PMID: 7814610

Abstract

Changes in VLDL triglyceride and VLDL apo B production were determined semiquantitatively in healthy young men by examining the effect of altering plasma insulin and/or FFA levels on the change in the slopes of the specific activity of VLDL [3H]triglyceride glycerol or the 131I-VLDL apo B versus time curves. In one study (n = 8) insulin was infused for 5 h using the euglycemic hyperinsulinemic clamp technique. Plasma FFA levels declined by approximately 80% (0.52 +/- 0.01 to 0.11 +/- 0.02 mmol/liter), VLDL triglyceride production decreased by 66.7 +/- 4.2% (P = 0.0001) and VLDL apo B production decreased by 51.7 +/- 10.6% (P = 0.003). In a second study (n = 8) heparin and Intralipid (Baxter Corp., Toronto, Canada) were infused with insulin to prevent the insulin-mediated fall in plasma FFA levels. Plasma FFA increased approximately twofold (0.43 +/- 0.05 to 0.82 + 0.13 mmol/liter), VLDL triglyceride production decreased to a lesser extent than with insulin alone (P = 0.006) (-31.8 +/- 9.5%, decrease from baseline P = 0.03) and VLDL apo B production did not decrease significantly (-6.3 +/- 13.6%, P = NS). In a third study (n = 8) when heparin and Intralipid were infused without insulin, FFA levels rose approximately twofold (0.53 +/- 0.04 to 0.85 +/- 0.1 mmol/liter), VLDL triglyceride production increased by 180.1 +/- 45.7% (P = 0.008) and VLDL apo B production increased by 94.2 +/- 28.7% (P = 0.05). We confirm our previous observation that acute hyperinsulinemia suppresses VLDL triglyceride and VLDL apo B production in healthy humans. In addition, we have demonstrated that elevation of plasma FFA levels acutely stimulates VLDL production in vivo in healthy young males. Elevating plasma FFA during hyperinsulinemia attenuates but does not completely abolish the suppressive effect of insulin on VLDL production, at least with respect to VLDL triglycerides. Therefore, in normal individuals the acute inhibition of VLDL production by insulin in vivo is only partly due to the suppression of plasma FFA, and may also be due to an FFA-independent process.

Full text

PDF
160

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adeli K., Theriault A. Insulin modulation of human apolipoprotein B mRNA translation: studies in an in vitro cell-free system from HepG2 cells. Biochem Cell Biol. 1992 Dec;70(12):1301–1312. doi: 10.1139/o92-177. [DOI] [PubMed] [Google Scholar]
  2. Arbeeny C. M., Meyers D. S., Bergquist K. E., Gregg R. E. Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster. J Lipid Res. 1992 Jun;33(6):843–851. [PubMed] [Google Scholar]
  3. Bartlett S. M., Gibbons G. F. Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin. Biochem J. 1988 Jan 1;249(1):37–43. doi: 10.1042/bj2490037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bergmann S. R., Carlson E., Dannen E., Sobel B. E. An improved assay with 4-(2-thiazolylazo)-resorcinol for non-esterified fatty acids in biological fluids. Clin Chim Acta. 1980 May 21;104(1):53–63. doi: 10.1016/0009-8981(80)90134-5. [DOI] [PubMed] [Google Scholar]
  5. Björnsson O. G., Duerden J. M., Bartlett S. M., Sparks J. D., Sparks C. E., Gibbons G. F. The role of pancreatic hormones in the regulation of lipid storage, oxidation and secretion in primary cultures of rat hepatocytes. Short- and long-term effects. Biochem J. 1992 Jan 15;281(Pt 2):381–386. doi: 10.1042/bj2810381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bonadonna R. C., Groop L. C., Zych K., Shank M., DeFronzo R. A. Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans. Am J Physiol. 1990 Nov;259(5 Pt 1):E736–E750. doi: 10.1152/ajpendo.1990.259.5.E736. [DOI] [PubMed] [Google Scholar]
  7. Borén J., Graham L., Wettesten M., Scott J., White A., Olofsson S. O. The assembly and secretion of ApoB 100-containing lipoproteins in Hep G2 cells. ApoB 100 is cotranslationally integrated into lipoproteins. J Biol Chem. 1992 May 15;267(14):9858–9867. [PubMed] [Google Scholar]
  8. Byrne C. D., Brindle N. P., Wang T. W., Hales C. N. Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells. Biochem J. 1991 Nov 15;280(Pt 1):99–104. doi: 10.1042/bj2800099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Byrne C. D., Wang T. W., Hales C. N. Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin. Biochem J. 1992 Nov 15;288(Pt 1):101–107. doi: 10.1042/bj2880101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cianflone K. M., Yasruel Z., Rodriguez M. A., Vas D., Sniderman A. D. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res. 1990 Nov;31(11):2045–2055. [PubMed] [Google Scholar]
  11. Coppack S. W., Jensen M. D., Miles J. M. In vivo regulation of lipolysis in humans. J Lipid Res. 1994 Feb;35(2):177–193. [PubMed] [Google Scholar]
  12. Dashti N., Williams D. L., Alaupovic P. Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J Lipid Res. 1989 Sep;30(9):1365–1373. [PubMed] [Google Scholar]
  13. Dashti N., Wolfbauer G. Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. J Lipid Res. 1987 Apr;28(4):423–436. [PubMed] [Google Scholar]
  14. Dixon J. L., Furukawa S., Ginsberg H. N. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem. 1991 Mar 15;266(8):5080–5086. [PubMed] [Google Scholar]
  15. Duerden J. M., Bartlett S. M., Gibbons G. F. Long-term maintenance of high rates of very-low-density-lipoprotein secretion in hepatocyte cultures. A model for studying the direct effects of insulin and insulin deficiency in vitro. Biochem J. 1989 Nov 1;263(3):937–943. doi: 10.1042/bj2630937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Durrington P. N., Newton R. S., Weinstein D. B., Steinberg D. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest. 1982 Jul;70(1):63–73. doi: 10.1172/JCI110604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  18. Fox J. C., Hay R. V. Eicosapentaenoic acid inhibits cell growth and triacylglycerol secretion in McA-RH7777 rat hepatoma cultures. Biochem J. 1992 Aug 15;286(Pt 1):305–312. doi: 10.1042/bj2860305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gibbons G. F., Bartlett S. M., Sparks C. E., Sparks J. D. Extracellular fatty acids are not utilized directly for the synthesis of very-low-density lipoprotein in primary cultures of rat hepatocytes. Biochem J. 1992 Nov 1;287(Pt 3):749–753. doi: 10.1042/bj2870749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jackson T. K., Salhanick A. I., Elovson J., Deichman M. L., Amatruda J. M. Insulin regulates apolipoprotein B turnover and phosphorylation in rat hepatocytes. J Clin Invest. 1990 Nov;86(5):1746–1751. doi: 10.1172/JCI114900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kaptein A., Roodenburg L., Princen H. M. Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apo B100 by the human hepatoma cell line Hep G2. Induction of apo A-I mRNA with no change of apo B100 mRNA. Biochem J. 1991 Sep 1;278(Pt 2):557–564. doi: 10.1042/bj2780557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Le N. A., Melish J. S., Roach B. C., Ginsberg H. N., Brown W. V. Direct measurement of apoprotein B specific activity in 125I-labeled lipoproteins. J Lipid Res. 1978 Jul;19(5):578–584. [PubMed] [Google Scholar]
  23. Levinson M., Oswald B., Quarfordt S. Serum factors influencing cultured hepatocyte exogenous and endogenous triglyceride. Am J Physiol. 1990 Jul;259(1 Pt 1):G15–G20. doi: 10.1152/ajpgi.1990.259.1.G15. [DOI] [PubMed] [Google Scholar]
  24. Lewis G. F., Uffelman K. D., Szeto L. W., Steiner G. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes. 1993 Jun;42(6):833–842. doi: 10.2337/diab.42.6.833. [DOI] [PubMed] [Google Scholar]
  25. Lewis G. F., Zinman B., Uffelman K. D., Szeto L., Weller B., Steiner G. VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin. Am J Physiol. 1994 Oct;267(4 Pt 1):E566–E572. doi: 10.1152/ajpendo.1994.267.4.E566. [DOI] [PubMed] [Google Scholar]
  26. Livesey J. H., Hodgkinson S. C., Roud H. R., Donald R. A. Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma. Clin Biochem. 1980 Aug;13(4):151–155. doi: 10.1016/s0009-9120(80)91040-1. [DOI] [PubMed] [Google Scholar]
  27. Patsch W., Franz S., Schonfeld G. Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J Clin Invest. 1983 May;71(5):1161–1174. doi: 10.1172/JCI110865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Patsch W., Gotto A. M., Jr, Patsch J. R. Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. The role of the insulin receptor. J Biol Chem. 1986 Jul 25;261(21):9603–9606. [PubMed] [Google Scholar]
  29. Pullinger C. R., North J. D., Teng B. B., Rifici V. A., Ronhild de Brito A. E., Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res. 1989 Jul;30(7):1065–1077. [PubMed] [Google Scholar]
  30. Rash J. M., Rothblat G. H., Sparks C. E. Lipoprotein apolipoprotein synthesis by human hepatoma cells in culture. Biochim Biophys Acta. 1981 Nov 23;666(2):294–298. doi: 10.1016/0005-2760(81)90120-x. [DOI] [PubMed] [Google Scholar]
  31. Reardon M. F., Poapst M. E., Uffelman K. D., Steiner G. Improved method for quantitation of B apoprotein in plasma lipoproteins by electroimmunoassay. Clin Chem. 1981 Jun;27(6):892–895. [PubMed] [Google Scholar]
  32. Reaven G. M., Greenfield M. S. Diabetic hypertriglyceridemia: evidence for three clinical syndromes. Diabetes. 1981;30(Suppl 2):66–75. doi: 10.2337/diab.30.2.s66. [DOI] [PubMed] [Google Scholar]
  33. Rizza R. A., Mandarino L. J., Gerich J. E. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol. 1981 Jun;240(6):E630–E639. doi: 10.1152/ajpendo.1981.240.6.E630. [DOI] [PubMed] [Google Scholar]
  34. Salam W. H., Wilcox H. G., Heimberg M. Effects of oleic acid on the biosynthesis of lipoprotein apoproteins and distribution into the very-low-density lipoprotein by the isolated perfused rat liver. Biochem J. 1988 May 1;251(3):809–816. doi: 10.1042/bj2510809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Salhanick A. I., Schwartz S. I., Amatruda J. M. Insulin inhibits apolipoprotein B secretion in isolated human hepatocytes. Metabolism. 1991 Mar;40(3):275–279. doi: 10.1016/0026-0495(91)90109-a. [DOI] [PubMed] [Google Scholar]
  36. Sparks C. E., Sparks J. D., Bolognino M., Salhanick A., Strumph P. S., Amatruda J. M. Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes. Metabolism. 1986 Dec;35(12):1128–1136. doi: 10.1016/0026-0495(86)90026-0. [DOI] [PubMed] [Google Scholar]
  37. Sparks J. D., Sparks C. E. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J Biol Chem. 1990 May 25;265(15):8854–8862. [PubMed] [Google Scholar]
  38. Sparks J. D., Sparks C. E., Miller L. L. Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes. Biochem J. 1989 Jul 1;261(1):83–88. doi: 10.1042/bj2610083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Steiner G., Haynes F. J., Yoshino G., Vranic M. Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics. Am J Physiol. 1984 Feb;246(2 Pt 1):E187–E192. doi: 10.1152/ajpendo.1984.246.2.E187. [DOI] [PubMed] [Google Scholar]
  40. Topping D. L., Mayes P. A. Insulin and non-esterified fatty acids. Acute regulators of lipogenesis in perfused rat liver. Biochem J. 1982 May 15;204(2):433–439. doi: 10.1042/bj2040433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Topping D. L., Storer G. B., Trimble R. P. Effects of flow rate and insulin on triacylglycerol secretion by perfused rat liver. Am J Physiol. 1988 Sep;255(3 Pt 1):E306–E313. doi: 10.1152/ajpendo.1988.255.3.E306. [DOI] [PubMed] [Google Scholar]
  42. Wang H., Chen X., Fisher E. A. N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes. J Clin Invest. 1993 Apr;91(4):1380–1389. doi: 10.1172/JCI116340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. White A. L., Graham D. L., LeGros J., Pease R. J., Scott J. Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. A function of the ability of apolipoprotein B to direct lipoprotein assembly and escape presecretory degradation. J Biol Chem. 1992 Aug 5;267(22):15657–15664. [PubMed] [Google Scholar]
  44. Wiggins D., Gibbons G. F. The lipolysis/esterification cycle of hepatic triacylglycerol. Its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas. Biochem J. 1992 Jun 1;284(Pt 2):457–462. doi: 10.1042/bj2840457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Woodside W. F., Heimberg M. Effects of anti-insulin serum, insulin, and glucose on output of triglycerides and on ketogenesis by the perfused rat liver. J Biol Chem. 1976 Jan 10;251(1):13–23. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES